About Oxford Gene Technology
Oxford Gene Technology is a Healthcare company based in Kidlington (United Kingdom) founded in 1995, and was acquired by Sysmex in May 2017. Genetics research and biomarker solutions are provided to research institutions. Its website ogt.com draws about 18 thousand monthly visits. Oxford Gene Technology offers products and services including CytoCell FISH, SureSeq NGS, and CytoSure Arrays. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Diversified. Its legal entity is OXFORD GENE TECHNOLOGY IP LIMITED.
Company details
Oxford Gene Technology was founded in 1995 and is headquartered in Kidlington, United Kingdom. Operations focus on the genetics sector, where NGS products, array products, and FISH probes are developed and supplied to clinical and academic institutions. Brands such as CytoSure for microarrays, Cytocell for FISH probes, and SureSeq for next-generation sequencing are utilized to support the identification of genetic variations associated with diseases.
Products & Services of Oxford Gene Technology
Oxford Gene Technology offers a comprehensive portfolio of products and services, including CytoCell FISH, SureSeq NGS, and CytoSure Arrays.
Probes for detecting genetic aberrations in cancer research.
Panels for genetic profiling in haematological and solid tumours.
Arrays for cytogenetic and rare disease analysis.
Apps and channels of Oxford Gene Technology
its YouTube channel OGT has 912 subscribers and 30 videos.
Videos from Oxford Gene Technology
The most watched videos on Oxford Gene Technology's YouTube channel, OGT (912 subscribers). Click a video to play it here.
More on OGT.
Funding Insights of Oxford Gene Technology
- Total Rounds 2
- Last Round Grant — $1.81M
- Investors Count 2
All 2 funding rounds of Oxford Gene Technology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2015 | $1.81M | Grant | – | – | |
| Dec 2011 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Oxford Gene Technology
Oxford Gene Technology has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Sysmex, European Union and SBRI Healthcare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Delivers business and technological solutions to identify and address healthcare challenges. | 2009 | sbrihealthcare.co.uk | Twickenham, United Kingdom | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Developer of diagnostic instruments, reagents, and related software | 1968 | sysmex.co.jp | Hyogo, Japan |
Investor details for Oxford Gene Technology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Oxford Gene Technology
28 people are tracked at Oxford Gene Technology (9 in leadership, 19 in team).
| Name | Role | Group |
|---|---|---|
James Reid | Head Of Data Analysis | Leadership |
Adrian Smith | CEO | Leadership |
Lucy Georgieva | Head Of Research | Leadership |
Duarte Molha | Head Of DNA Design | Leadership |
Greg Williams | Group Chief Financial Officer | Leadership |
Jace Doshier | Vice President Of Sales And Service, North America | Leadership |
Tori Anthony-Dubernet | Director, European Sales & Support | Leadership |
Jolyon Holdstock | Director Of Computational Biology | Leadership |
Michael Ornelas Mba, Cgcm (ASCP) | Director Of Support And Services, North America | Leadership |
Katherine Melville | Account Manager | Team |
Dave Bohanna | Business Development Manager (ngs + Microarrays) | Team |
Harry Petch-Smith | Computational Biologist | Team |
Natalie Milner | Senior Molecular Biologist | Team |
Kicki Bergefall | Field Application Support Manager | Team |
Graham Halford | Field Application Specialist | Team |
Michel Viau | Country Sales Manager-canada | Team |
Tony Lenhardt | Financial Controller | Team |
Nora Ashley Hart | Business Development Manager, FISH | Team |
Matthew Parnall | Field Application Specialist | Team |
Georgia Marshall | Senior Management Accountant | Team |
8 more people are available in the full profile.
Complete people profiles for Oxford Gene Technology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Oxford Gene Technology
4 dated milestones of Oxford Gene Technology across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Oxford Gene Technology is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $1.8M.
- Exit Acquired by Sysmex.
Web traffic of Oxford Gene Technology
The website of Oxford Gene Technology (ogt.com) receives about 18K visits a month.
- Monthly visits18K
▼ 19.9% vs previous month
Websites whose visitors overlap most with Oxford Gene Technology. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| sptlabtech.com | 100% | 23.8K | #1,239,423 | View details | |
| covaris.com | 92% | 18.2K | #1,391,674 | View details | |
glccontario.tripod.com | glccontario.tripod.com | 91% | – | ||
| biocare.net | 90% | 23.2K | #1,197,634 | View details | |
| novogene.com | 75% | 366.1K | #104,051 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Oxford Gene Technology
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
2 companies that operate in the same segment as Oxford Gene Technology (Genomics & Gene Therapy Platforms) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Oxford Gene Technology
Complete news archive for Oxford Gene Technology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oxford Gene Technology
Oxford Gene Technology was founded in 1995 and raised its 1st funding round 16 years after it was founded.
Oxford Gene Technology is headquartered in Kidlington, United Kingdom. It is registered at Kidlington, Oxfordshire, United Kingdom.
Oxford Gene Technology was founded in 1995 and is headquartered in Kidlington, United Kingdom. Operations focus on the genetics sector, where NGS products, array products, and FISH probes are developed and supplied to clinical and academic institutions. Brands such as CytoSure for microarrays, Cytocell for FISH probes, and SureSeq for next-generation sequencing are utilized to support the identification of genetic variations associated with diseases.
Oxford Gene Technology offers CytoCell FISH, SureSeq NGS, and CytoSure Arrays.
Oxford Gene Technology has 3 investors. Key investors include Sysmex, European Union, and SBRI Healthcare.
Oxford Gene Technology operates through Oxford Gene Technology Ip Limited.
Yes. Oxford Gene Technology was acquired by Sysmex in May 2017.